Newsfeeds - Spark Newswire

5 minute read

Uncategorized

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal

Today, 5:46 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24)

ADVM

3 minute read

Uncategorized

Jazz To Present Data At ASCO And EHA 2021 Meetings

By Bill Haddad

Today, 5:46 AM

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that it and its investigator sponsors will present four new abstracts at the virtual American Society of Clinical Oncology (ASCO) Annual Meeting from June

JAZZ

1 minute read

Uncategorized

Cramer Advises Viewers On Suncor, Jazz And More

By Craig Jones

Today, 5:46 AM

On CNBC's "Mad Money Lightning Round," Jim Cramer said that in the energy space he is recommending only Chevron Corporation (NYSE: CVX) and Pioneer Natural Resources Co (N

AEVA

2 minute read

Uncategorized

Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio

By Jelena Martinovic

Today, 5:46 AM

The biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ), has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc. (NASDAQ: GWPH).

GWPH

20 minute read

Uncategorized

Earnings Scheduled For May 4, 2021

By Benzinga Insights

Today, 5:46 AM

Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million.

ACLS

8 minute read

Uncategorized

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge

By Shanthi Rexaline

Today, 5:46 AM

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.

ABUS

4 minute read

Uncategorized

Novel Approach to Cancer From Lixte Biotechnology Could Be a General way to Enhance a Variety of Standard Treatments

By Silvia Munoz Campo

Today, 5:46 AM

The following article is sponsored by Lixte Biotechnology Holdings, Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only.

JAZZ

1 minute read

Wells Fargo Maintains Overweight on Jazz Pharmaceuticals, Raises Price Target to $189

By Vick Meyer

Today, 5:46 AM

Wells Fargo maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price target from $186 to $189.

JAZZ

1 minute read

News

PharmaMar and Jazz Pharmaceuticals Announce the U.S. License Agreement for Lurbinectedin is Effective with the Expiration of the HSR Waiting Period

By Charles Gross

Today, 5:46 AM

PharmaMar (MSE:PHM) and Jazz Pharmaceuticals plc (NASDAQ:JAZZ) announce that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act…

JAZZ

3 minute read

Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea

By Charles Gross

Today, 5:46 AM

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that the European Commission approved SunosiÂ® (solriamfetol) to improve wakefulness and reduce…

JAZZ